Cleared Special

K151867 - STA R MAX

K151867 is an FDA 510(k) clearance for STA R MAX, manufactured by Diagnostica Stago S.A.S. The device is a Class 2 Hematology device with product code JPA cleared through the Special 510(k) pathway after a 29-day FDA review.

K151867 · Diagnostica Stago S.A.S · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2015
Decision
29d
Days
Class 2
Risk

K151867 is an FDA 510(k) clearance for the STA R MAX. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Diagnostica Stago S.A.S (Gennevilliers, FR). The FDA issued a Cleared decision on August 7, 2015 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Diagnostica Stago S.A.S devices

FDA 510(k) Submission Details - K151867

510(k) Number K151867 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 09, 2015
Decision Date August 07, 2015
Days to Decision 29 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 113d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Consultant

Diagnostica Stago, Incorporated
JAMES MONROE

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 164
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K151867.
Sysmex Automated Blood Coagulation Analyzer CS-2100i
K161312 · Siemens Healthcare Diagnostics Products GmbH · Sep 2016
Sysmex Automated Blood Coagulation Analyzer CS-2100i
K151259 · Siemens Healthcare Diagnostics Products GmbH · Jan 2016
Sysmex Automated Blood Coagulation Analyzer CS-5100
K150678 · Siemens Healthcare Diagnostic Products GmbH · Jan 2016
CORA (Coagulation Resonance Analysis) System
K150041 · Coramed Technologies, LLC · Jun 2015
STA COMPACT MAX
K130090 · Diagnostica Stago, Incorporated · Feb 2013
EX-TEM. FIB-TEM, AND AP-TEM FOR ROTEM DELTA THROMBOELASTOMETRY SYSTEM
K101533 · Tem Innovations GmbH · Aug 2011